Guardant Health (GH) insider Musa Tariq reports 580 shares sold in 2026
Rhea-AI Filing Summary
Guardant Health (GH) notice of proposed insider sales by Musa Tariq. The filing lists prior sales of common stock in three separate transactions: 03/18/2026 — 348 shares (aggregate $30,655), 04/16/2026 — 116 shares (aggregate $9,840), and 05/18/2026 — 116 shares (aggregate $11,131).
The filing also records a restricted stock lapse on 06/15/2026 associated with equity compensation and lists brokerage details for Charles Schwab & Co. The notice records proposed sale activity under Form 144; timing and method of any future sales are not detailed beyond the listed items.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notice showing small insider dispositions tied to equity compensation.
Form 144 is a regulatory notice required for certain proposed sales by affiliates. The filing lists three recent dispositions totaling 580 shares across March–May 2026 and notes a restricted stock lapse dated 06/15/2026 tied to equity compensation.
These quantities are modest in isolation; cash‑flow treatment and any planned future sales are not described in the excerpt. Subsequent public filings would show whether further transactions occur under the notice.